Back

Biodegradable polymer everolimus-eluting stents versus durable polymer everolimus-eluting stents in diabetic patients : a 3-year propensity-matched study

1 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Percutaneous coronary syndrome: pharma and devices Stents ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Hiroaki Matsuda

Nagoya Heart Center, Nagoya (Japan)

26 More presentations in this session

Presentation thumbnail
Doctor G. Gallone (Turin, IT)
Abstract Slides
Presentation thumbnail
Doctor S. Dani (Ahmedabad, IN)
Presentation thumbnail
Doctor I. Menown (Craigavon, GB)
Abstract
Presentation thumbnail
Miss L. Kerkmeijer (Zwolle, NL)
Abstract Slides
Presentation thumbnail
Professor K. Cha (Pusan, KR)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Percutaneous coronary syndrome: pharma and devices

The Event

Event poster

ESC Congress 2019

1 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Diabetes mellitus and 10-year outcomes after percutaneous coronary intervention with drug eluting stents: insights from the DECADE cooperation
30 August 2026
thumbnail
Congress Presentation
Bioresorbable vascular scaffolds - a single center experience
9 March 2024
thumbnail
Congress Presentation
Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study
1 September 2020
thumbnail
Congress Presentation
Percutaneous coronary intervention with everolimus-eluting stents versus coronary artery bypass surgery in patients with stable angina and an isolated proximal left anterior descending artery disease
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources